No Data
Express News | Seelos : Expects to Continue to Report in Its Form 10-Q That Substantial Doubt Exists About Its Ability to Continue as Going Concern for One Year
Express News | Seelos Therapeutics: Considering Possible Effect of Matter on Evaluation of Internal Control Over Financial Reporting, Disclosure Controls, Procedures
Express News | Seelos Therapeutics Inc: Files for Non Timely 10-Q With U.S. SEC
Express News | Seelos Therapeutics Commences Chapter 11 Proceedings- Court Filing
RFK and the 'MAHA Trade': Vaccine Makers Down, Psychedelic Shares up
12 Health Care Stocks Moving In Tuesday's Intraday Session
No Data
No Data